Literature DB >> 2916551

The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias.

P I Tarr1, M A Neill, J Allen, C J Siccardi, S L Watkins, R O Hickman.   

Abstract

The annual incidence of the hemolytic-uremic syndrome was determined for the well-defined population of King County, Washington, between 1971 and 1986, inclusive, to ascertain temporal trends in the epidemiology of this disease. The average annual incidence rose from 0.69 cases per 100,000 children under age 15 years between 1971 and 1975 to 1.77 cases between 1976 and 1980 and 1.74 cases between 1981 and 1986. The mean hematocrits, platelet counts, and blood urea nitrogen and creatinine concentrations on admission were similar in all periods, as were the mean length of hospital stay and the proportions of patients requiring erythrocyte and/or platelet transfusions and dialysis. These results indicate that the increased incidence of hemolytic-uremic syndrome in childhood has been sustained in King County, Washington, and that this increase is not due to ascertainment bias caused by the diagnosis of less severely ill cases. Further investigations are needed to determine whether this increased incidence is being experienced in other populations and to assess strategies for the prevention of microangiopathic sequelae to hemorrhagic colitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916551     DOI: 10.1093/oxfordjournals.aje.a115170

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Diarrhea-associated hemolytic uremic syndrome in southern Alberta: A long-term single-centre experience.

Authors:  Silviu Grisaru; Julian P Midgley; Lorraine A Hamiwka; Andrew W Wade; Susan M Samuel
Journal:  Paediatr Child Health       Date:  2011-06       Impact factor: 2.253

2.  Hemolytic uremic syndrome due to Escherichia coli O157: H7 in a child with multiple infections.

Authors:  D B Ornt; P M Griffin; J G Wells; K R Powell
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

3.  Haemolytic uraemic syndrome in the defined population of northeast of Scotland.

Authors:  I A Abu-Arafeh; P J Smail; G G Youngson; I A Auchterlonie
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

4.  A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California. A mandate for improved surveillance.

Authors:  A M Shefer; D Koo; S B Werner; E D Mintz; R Baron; J G Wells; T J Barrett; M Ginsberg; R Bryant; S Abbott; P M Griffin
Journal:  West J Med       Date:  1996 Jul-Aug

5.  Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group.

Authors:  A Gianviti; F Rosmini; A Caprioli; R Corona; M C Matteucci; F Principato; I Luzzi; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

6.  Myocarditis and haemolytic uraemic syndrome.

Authors:  I Abu-Arafeh; E Gray; G Youngson; I Auchterlonie; G Russell
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

7.  The prevalence of Escherichia coli O157.H7 in dairy and beef cattle in Washington State.

Authors:  D D Hancock; T E Besser; M L Kinsel; P I Tarr; D H Rice; M G Paros
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

8.  Sequelae of haemolytic uraemic syndrome.

Authors:  A Schlieper; P C Rowe; E Orrbine; M Zoubek; W Clark; N Wolfish; P N McLaine
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

9.  Non-iterative sampling-based Bayesian methods for identifying changepoints in the sequence of cases of haemolytic uraemic syndrome.

Authors:  Guo-Liang Tian; Kai Wang Ng; Kai-Can Li; Ming Tan
Journal:  Comput Stat Data Anal       Date:  2009-07-01       Impact factor: 1.681

Review 10.  Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome.

Authors:  J A O'Brien; S K Van Why; M S Keller; K M Gaudio; T L Kennedy; N J Siegel
Journal:  Yale J Biol Med       Date:  1994 Jan-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.